[Analysis of acute myocardial infarction one month after stent implantation]

Guang-yuan Song1, Li-jian Gao, Yue-jin Yang

  • 1Center of Coronary Heart Disease, Cardiovascular Institute & Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China.

Zhonghua Nei Ke Za Zhi
|January 19, 2010
PubMed

Insights

ST-elevated acute myocardial infarction (STEAMI) one month after percutaneous coronary intervention (PCI) is more often caused by new lesions than stent thrombosis. Diabetes and drug-eluting stents increase late thrombosis risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • ST-elevated acute myocardial infarction (STEAMI) following percutaneous coronary intervention (PCI) requires understanding of underlying causes.
  • Distinguishing between new-lesion myocardial infarction and in-stent thrombosis is crucial for patient management.

Purpose of the Study:

  • To investigate the etiological factors of STEAMI occurring within one month after a prior successful PCI.
  • To identify patient and procedural characteristics associated with different causes of early post-PCI STEAMI.

Main Methods:

  • A cohort of 192 patients (40-79 years) with successful prior PCI who presented with STEAMI requiring primary PCI was analyzed.
  • Lesions causing STEAMI were categorized as new-lesion or late stent thrombosis based on angiographic location relative to previous stents.
  • Patient demographics, previous angiographic findings, stent types, and procedural outcomes were recorded.

Main Results:

  • New-lesion myocardial infarction was the predominant cause (75%) of early STEAMI, while late stent thrombosis accounted for 25%.
  • Patients with late stent thrombosis had a significantly longer interval from previous PCI compared to those with new-lesion MI.
  • Diabetes mellitus and the use of drug-eluting stents were significantly associated with an increased risk of late stent thrombosis.

Conclusions:

  • Early STEAMI post-PCI is more frequently attributed to progression of previously insignificant lesions rather than late stent thrombosis.
  • Diabetes mellitus and drug-eluting stents are risk factors for late stent thrombosis, suggesting a need for intensified antiplatelet therapy in these patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...